Skip to content
Screener

Editas Medicine EDIT Q3 2025 earnings

Reported November 10, 2025 · Before market open

Revenue$7.5MMiss by $910.8K
EPS-$0.28Beat by $0.10
Revenue estimate$8.5M
EPS estimate-$0.38

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$4.5M
EPS estimate-$0.21

FAQ

When did Editas Medicine report Q3 2025 earnings?
Editas Medicine (EDIT) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Editas Medicine's Q3 2025 revenue and EPS?
Editas Medicine reported revenue of $7.5M and eps of $-0.28 for Q3 2025.
Did Editas Medicine beat estimates in Q3 2025?
Revenue missed the consensus estimate of $8.5M by $910.8K. EPS beat the consensus estimate of $-0.38 by $0.10.
How did Editas Medicine's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12265.6% from $61.0K a year earlier and eps grew 62.7% from $-0.75.
Where can I find Editas Medicine's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001650664-25-000153) and the 10-Q periodic report (0001650664-25-000156) directly on SEC EDGAR. The filing index links above go to sec.gov.